Clinical Trials Logo

Recurrent Vulvar Carcinoma clinical trials

View clinical trials related to Recurrent Vulvar Carcinoma.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03987555 Recruiting - Solid Tumor, Adult Clinical Trials

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

Start date: November 11, 2019
Phase:
Study type: Observational

The goals of this prospective, observational cohort study are to determine the feasibility of implementing paclitaxel therapeutic drug monitoring for cancer patients and explore the relationship between paclitaxel drug exposure and the development of neuropathic symptoms. This trial studies if paclitaxel can be consistently measured in the blood of patients with solid tumors undergoing paclitaxel treatment. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Nerve damage is one of the most common and severe side effects of paclitaxel. The ability to consistently measure paclitaxel in the blood may allow doctors to control the dose of paclitaxel, so that enough chemotherapy is given to kill the cancer, but the side effect of nerve damage is reduced.